Consumers Are Replacing Pharmaceuticals With Medical Marijuana

The Fresh Toast

Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.

Trending Sources

Europe Cannabis and Pain Management Devices on Cancer Pain Market – Major Technology Giants in Buzz Again | Cannabis Players:, GW Pharmaceuticals, UNIMED PHARMACEUTICALS, Valeant Pharmaceuticals, Insys Therapeutics

Cannabis Law Report

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals.

Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers

Cannabis Life Network

8, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […].

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Cannabis Law Report

TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC.

Benchmark Signs A Strategic Cooperation With China-Based Zejiang Yatai Pharmaceutical

Canna Newswire

To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co.,

Benchmark Signs Definitive Investment Cooperation Agreement with China-Based Zhejiang Yatai Pharmaceutical

Canna Newswire

CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol.

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB:

International Cannabis to Supply New Zealand’s NUBU Pharmaceuticals With Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products

Cannabis Law Report

Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.

Cannabis Wire Investigates Lobbying Power Of “Greenwich Biosciences” The US Arm of GW Pharmaceuticals

Cannabis Law Report

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain.

Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc

Cannabis Law Report

Forbes report.

Press Release: Cabot Wealth Management Upped Gw Pharmaceuticals Plc (GWPH) Stake by $914,524; Share Price Declined; Unitedhealth Group (UNH) Holder New England Investment & Retirement Group Has Raised Stake

Cannabis Law Report

Cabot Wealth Management Inc increased its stake in Gw Pharmaceuticals Plc (GWPH) by 34.2% The institutional investor held 20,865 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $3.60M, up from 15,548 at the end of the previous reported quarter.

Canadian Company Signs “Definitive Agreement” With China-based Zhejiang Yatai Pharmaceutical Co., Ltd

Cannabis Law Report

CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Portugal: KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. for the production R&D of pharmaceutical grade standardised cannabis.

Cannabis Law Report

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.

UK Opinion Piece: The Pharmaceutical Journal – The bar must not be lowered for medical cannabis

Cannabis Law Report

There have been calls to loosen regulations around medical cannabis to increase access for those who need it, but the government must resist and view cannabis with the same scrutiny as any other new medicine. Read all at ( paywall) [link]. Medical Cannabis News

Thailand: Press Release Thailand Govt Pharma Organization “Pharmaceutical Organization, Department of Medical Cooperation, Research on Medical Marijuana Extracts For cancer patients with neurodegenerative epilepsy And nervous pain”

Cannabis Law Report

Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization.

Australia’s MGC Pharmaceuticals finally gets cannabis cultivation research licence from the Australian Office of Drug Control.

Cannabis Law Report

Here’s the press release. The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research.

Why The US Has Higher Drug Prices Than Other Countries

The Fresh Toast

can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals

The Truth About CBD

Nature's Way Medicine

Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this.

CBD 87

Dr. Sanjay Gupta: Researchers Are Focused On Treating Autism With Marijuana

The Fresh Toast

Cannabis Featured Medical Marijuana News autism CBD oil Epilepsy GW Pharmaceuticals Sanjay GuptaLeading marijuana researchers now believe a cannabis compound could treat autism symptoms.

Innovative Treatment for Seizures Released by Nature’s Grace and Wellness & JC Pharma Inc

Canna Newswire

MEDICAL CANNABIS PHARMACEUTICALSTwo Health and Wellness Powerhouses Collaborate to Help Those Suffering from Seizures Through an Innovative and Fast-Acting Intranasal Spray Solution. CHICAGO – July 11, 2019 / Canna Newswire / – Nature’s Grace and Wellness & JC Pharma, Inc.

Opioids and Medical Cannabis: An Update on the Latest Information

Medical Marijuana 411

Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article.

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 65

CBD to the Rescue

Project CBD

Life-threatening side effects from pharmaceuticals led one man to try cannabis. In this testimonial, he shares how cannabis helped him overcome refractory lockjaw and severe nerve pain

Portugal Shoots Down Recreational Proposals As Medicinal Weed Goes Live

Cannabis Law Report

Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.

The Evolving Regulatory Status of Cannabidiol

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

The Evolving Regulatory Status of Cannabidiol

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

When is CBD Legal and When Isn't It?

Project CBD

Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.

Cannabinoids for Scleroderma

Project CBD

Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials.

Synthetic CBD and Solvents in Epidiolex?

Cannabis Life Network

GW Pharmaceuticals has been creating unusual blends of clinical cannabis for over two decades. Blog Featured Health Marijuana News Science Technology abnormal cbd CBD Epidiolex ethanol gpr GW Pharmaceuticals synthetic cbd

10 Tips for Buying CBD Oil

Project CBD

In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy.

Oil 285

Today’s Answer of the Day

TheAnswerPage

Has the American Epilepsy Society (AES) published a position statement on the use of CBD for the treatment of seizures? Yes, the AES has.

10 Tips for Buying Hemp-Derived CBD Products

Project CBD

How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.

DEA 236

CBD & Cannabis for Pets in Pain

Project CBD

Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys.

Pets 282